During her PhD at the University of Oxford, Dr Blanchard-Rohner conducted several clinical trials and observational studies to better understand the kinetics of the humoral immune response following vaccination (Blanchard Rohner Blood 2008) and the role of memory B cells in the development of long-term immunity following protein polysaccharide vaccines (Blanchard Rohner Journal of Immunology 2008). She also assessed the role of maternal antibodies in the immune response to vaccination in young infants.

In parallel with her clinical training, Dr. Blanchard-Rohner conducted research projects on the vaccination of pregnant women to protect newborns against influenza and Bordetella pertussis.

During her time as “Cheffe de Clinique scientifique,” she conducted a phase II/III clinical trial assessing the immune response following a new vaccine against Bordetella pertussis using a recombinant pertussis toxin in teenagers (Blanchard Rohner, Clinical Infectious Diseases 2019).

Currently, she is the head of the Unit of Paediatric Immunology, Vaccinology, and Rheumatology in the Children’s Hospital of the HUG. She is responsible for the care of all children with immunological problems, in particular those with a primary or secondary immune defect, as well as children with autoimmune or autoinflammatory disorders. She also oversees the vaccination of children with various pathologies. Her aim is to better define the immune response to vaccination in immunosuppressed children and to further understand autoinflammatory disorders such as PFAPA syndrome.

Read more about her: https://www.hug.ch/enfants-ados/vaccinologie-pediatrique/dre-geraldine-blanchard-rohner